Compare LTRX & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LTRX | PMI |
|---|---|---|
| Founded | 1989 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | |
| Sector | Telecommunications | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.5M | 202.7M |
| IPO Year | 2000 | 2025 |
| Metric | LTRX | PMI |
|---|---|---|
| Price | $5.55 | $3.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.17 | N/A |
| AVG Volume (30 Days) | 299.4K | ★ 2.3M |
| Earning Date | 11-05-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $118,294,000.00 | $4,767,000.00 |
| Revenue This Year | $4.59 | N/A |
| Revenue Next Year | $12.20 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 8.81 |
| 52 Week Low | $1.91 | $1.90 |
| 52 Week High | $5.89 | $13.68 |
| Indicator | LTRX | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 64.57 | N/A |
| Support Level | $4.88 | N/A |
| Resistance Level | $5.89 | N/A |
| Average True Range (ATR) | 0.31 | 0.00 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 77.18 | 0.00 |
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.